Volume 21 Issue 12, December 2003

Beyond belief

Companies jostle for access to public markets

• Aaron Bouchie

Germany biotech gets second chance

• Cormac Sheridan

Regulators equivocate on safety of clones

• Kendall Powell

Biotechs await single European financial market

• Sabine Louët

US bioethics committee weighs in

• Jeffrey L. Fox

Europe responds to UK's GM field trials

• Peter Mitchell

EU wrangles internally over safety of donated tissues and cells

• Peter Vermij

News In Brief

Ultrafast DNA sequencing

• Jim Kling

UK field-scale evaluations answer wrong questions

• Bruce Chassy
• Catherine Carter
• Steven H Strauss

Vox populi and public policy: why should we care?

• Henry I Miller

Time to drop the language of 'consensus'

• Leigh Turner

Biotechnology and the UN's Millennium Development Goals

• Tara Acharya
• Abdallah S Daar
• Peter A Singer

Biotech IPOs: handle with care

• Tom Jacobs

A patently negative view of industry

• Philip Grubb

Unlocking the money-making potential of RNAi

• Ken Howard

Fluorescent proteins with ties that bind

• Timothy A Ryan

Mending the message

• Mariano A Garcia-Blanco

Bt-resistance management—theory meets data

• Fred Gould

Cloning by numbers

• Louis-Marie Houdebine

UK farm-scale evaluations of transgenic herbicide-tolerant crops

• David A Andow

Research notes

Approaches for the sequence-specific knockdown of mRNA

• Lisa J Scherer
• John J Rossi

Antibiotic optimization via in vitro glycorandomization

• Xun Fu
• Christoph Albermann
• Jon S Thorson

Sialylated endogenous glycoconjugates in plant cells

• Miti M Shah
• Kazuhito Fujiyama
• Lokesh Joshi

Fluorobodies combine GFP fluorescence with the binding characteristics of antibodies

• Ahmet Zeytun
• Andreas Jeromin
• Andrew RM Bradbury

An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteria

• Xiao-Qing Qiu
• He Wang
• George Y Wu

Design of multivalent complexes using the barnase·barstar module

• Sergey M Deyev
• Robert Waibel
• Andreas Plückthun

Transgenic plants expressing two Bacillus thuringiensis toxins delay insect resistance evolution

• Jian-Zhou Zhao
• Jun Cao
• Anthony M Shelton

An archaeal endoribonuclease catalyzes cis- and trans- nonspliceosomal splicing in mouse cells

• Giancarlo Deidda
• Nicoletta Rossi
• Glauco P Tocchini-Valentini

Genetically targeted chromophore-assisted light inactivation

• Oded Tour
• Rene M Meijer
• Roger Y Tsien

Analyzing antibody specificity with whole proteome microarrays

• Gregory A Michaud
• Michael Salcius
• Barry I Schweitzer

Erratum: Why biotech don't pay dividends–yet

• Tom Jacobs

Erratum: New biotech hubs may emerge as industry matures

• Paroma Basu

Erratum: Invention and commercialization in optical bioimaging

• Daniel L. Farkas

The patent gamble: strategic insights for playing the worldwide patent game

• William A Barrett

Recent patent applications relating to biological separations

People

Bioseparation & Antibodies

Toward an integrated biotechnological engineering education program: a Canadian perspective

• Patrick Vermette
• Pierre Proulx
• Bernard Marcos